Next Article in Journal
Fabrication of a Novel and Ultrasensitive Label-Free Electrochemical Aptasensor Based on Gold Nanostructure for Detection of Homocysteine
Previous Article in Journal
Quantum Dot-Sensitised Estrogen Receptor-α-Based Biosensor for 17β-Estradiol
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19

1
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt
2
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Port-Said University, Port Said 42526, Egypt
3
Institute of Medicinal and Pharmaceutical Chemistry, Teschnische Universität Braunschweig, 38106 Braunschweig, Germany
4
Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa 616, Oman
5
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt
*
Author to whom correspondence should be addressed.
Submission received: 27 December 2022 / Revised: 26 January 2023 / Accepted: 7 February 2023 / Published: 8 February 2023
(This article belongs to the Section Biosensor Materials)

Abstract

:
An innovative polymer-based electro-sensor decorated with Tb nanoparticles has been developed for the first time. The fabricated sensor was utilized for trace determination of favipiravir (FAV), a recently US FDA-approved antiviral drug for the treatment of COVID-19. Different techniques, including ultraviolet-visible spectrophotometry (UV-VIS), cyclic voltammetry (CV), scanning electron microscope (SEM), X-ray Diffraction (XRD) and electrochemical impedance spectroscopy (EIS), were applied for the characterization of the developed electrode TbNPs@ poly m-THB/PGE. Various experimental variables, including pH, potential range, polymer concentration, number of cycles, scan rate and deposition time, were optimized. Moreover, different voltammetric parameters were examined and optimized. The presented SWV method showed linearity over the range of 10–150 × 10−9 M with a good correlation coefficient (R = 0.9994), and the detection limit (LOD) reached 3.1 × 10−9 M. The proposed method was applied for the quantification of FAV in tablet dosage forms and in human plasma without any interference from complex matrices, obtaining good % recovery results (98.58–101.93%).

Graphical Abstract

1. Introduction

Favipiravir (FAV), 6-fluoro-3-hydroxy-2-pyrazinecarboxamide, is a promising antiviral pro-drug belonging to the RNA polymerase inhibitors. It was first introduced in Japan in 2014 as an anti-influenza agent, and it was also applied to treat other viruses [1]. In 2019, it was proven to be safe and effective against COVID-19, a global pandemic with outbreaks all over the world, as the World Health Organization (WHO) officially declared in March 2020. COVID-19 causes severe respiratory syndrome leading to a serious disease that affects different organs, including the kidneys, liver and central nervous system [2].
Although the pandemic crest has diminished lately due to several considerations, such as global vaccination and enhanced health awareness, however, its endemicity is said to be meaningless or at least only transitional. Expectations for infection spikes are high, which may be owed to the removal of restrictive measures as well as viral mutations [3,4]. Therefore, it was recommended to establish a sensitive, cost-effective and selective analytical method for the estimation of COVID-19 defense drugs such as FAV in biological fluids for routine drug quality control and further clinical studies’ monitoring.
Although different analytical methods were published for the estimation of FAV, including spectrophotometric and spectrofluorimetric [5,6,7,8,9], thin layer chromatography [10,11], and liquid chromatography methods [5,7,12,13,14,15,16,17]. However, only a few voltammetric and electrochemical methods have been reported for the estimation of FAV till now [18,19,20,21,22,23]. Electrochemical techniques are currently more frequently used due to their simplicity, sensitivity, environment-friendly and ready availability. Besides, varying modifications of carbon-based electrodes have currently attracted considerable attention, where different nanomaterials [24,25] could be utilized for the detection of several analytes in complex matrices, such as pharmaceutical formulations and biological fluids. A pencil graphite electrode (PGE) is a working electrode that is commonly used currently. This can be attributed to its superb electrochemical properties like high conductivity, low cost, simplicity in modification and wide commercial availability [26,27,28]. Henceforth, it was recommended to establish a sensitive, selective and cost-effective electrochemical analytical approach for the estimation of FAV in human plasma for drug monitoring and further clinical studies.
Moreover, electro-polymerization has drawn great attention recently as one promising approach in electrochemistry [29]. Polymer-modified electrodes are used in the manufacturing of batteries or supercapacitors, organic light-emitting diodes and biosensors. The deposited polymers on the substrate surface own many properties like advanced electrical conductivity, redox mediating capabilities and specific adhesive and/or binding properties. These polymers are promising in electrode modification because it generally results in creating polymer film which is uniform and strongly adherent to the electrode surface [30]. Conducting polymers with extended π-π conjugated systems have been used in the synthesis and preparation of various electrochemical sensors [31,32,33] owing to their high conductivity and their redox properties. In addition, polymerization using polyhydroxy aromatic compounds has shown good stability, reproducibility, more active surface area and homogeneity in electrochemical deposition [34]. In the represented research, innovative polymer layers were created for the first time via utilizing phloroglucinol, a trihydroxy benzene compound (m-THB), which was electropolymerized in order to form electro-active layers on the surface of a solid surface of PGE.
Additional enhancement of the electrode activity and sensitivity was accomplished by the integration of metal nanostructures. In this article, we investigate the behavior of terbium nanocomposites. Terbium (Tb) is one of the lanthanide metals that has the ability to create more electronic charges or holes, efficiently generating an electron transfer pathway due to possessing two states of valence (Tb3+ and Tb4+). Hence, the incorporation of Tb3+ nanoparticles (TbNPS) into any electrode modification is successfully enhancing the electronic conductivity, electrocatalytic activity, general electrochemical behavior, overall electrochemical performance and hence method sensitivity [35,36,37]. The incorporation of m-THB polymerized layers and TbNPS not only improves polymer characteristics but also provides excellent performance by increasing the active sites of the electrode surface utilizing these hybrid components.
Herein, a new strategy was introduced involving the design of the hybrid nanostructure composed of m-THB polymer layers over the PGE surface. Further, the incorporation of TbNPS overlaying the electro-active polymer layers was performed. The prepared electrode was characterized by UV-VIS spectrophotometry, scanning electron microscope (SEM), CV, SWV, and EIS methods. Besides, the modified sensor’s electrochemical performance was considered in monitoring the electro-oxidation of FAV in human plasma and tablets. The proposed SWV method is simple, highly sensitive and can be recommended for therapeutic drug monitoring (TDM) and various clinical laboratories for further pharmacokinetic studies.

2. Materials and Methods

2.1. Materials

FAV (purity = 99.0%) authentic standard was obtained from EIPICo. (Tenth of Ramadan City, Egypt). Avipiravir® tablets (200 mg of FAV per tablet) were supplied from EVA Pharm (Giza, Egypt).
All chemicals and solvents were of analytical grades. Terbium chloride (III) hexahydrate (TbCl3 · 6H2O), phloroglucinol (m-trihydroxy benzene, m-THB), potassium chloride, potassium ferrocyanide were obtained from Sigma–Aldrich. HPLC grade methanol was obtained from Sigma–Aldrich Co. (St. Louis, MO, USA). Phosphate buffer (0.1 M, pH 4.0–9.0) was prepared using sodium dihydrogen phosphate and di sodium hydrogen phosphate (El-Nasr Pharmaceutical Chemicals Co., Cairo, Egypt); pH was adjusted by 0.2 M NaOH. Rotring (HB) pencil leads (0.5 mm × 60 mm) were purchased from a local market.
Blank human plasma samples (fresh frozen plasma, B-Rh+) were supplied from Assiut University Hospitals Blood Bank (Assiut, Egypt).

2.2. Instruments

Voltammetric measurements were done using a Princeton VersaSTAT MC (VersaSTAT 3, model RE-1, Princeton Applied Research, AMETEK, Easttown Township, PA, USA), which consists of a 3-electrode electroanalytical cell (Ag/AgCl, 3 M KCl reference electrode, a platinum wire auxiliary electrode and PGE either bare or modified was a working electrode). Ultrasonic cleaner (Cole-Parmer, Chicago, IL, USA), Sartorious handy balance-H51 (Hannover, Germany), Hanna pH meter HI 4222 (Hanna Instruments Brazil, Sao Paulo, Brazil), Boeco laboratory centrifuge U-320® (, Hamburg, Germany), FALC vortex-MIX (FALC Instruments, Treviglio, Italy), and Scanning electron microscope; SEM (JEOL JSM-5400 LV instrument, Oxford, MO, USA) were used. UV–VIS spectra of the modified layers were recorded using a UV-visible spectrophotometer (UV-1601PC, Shimadzu, Kyoto, Japan) with 1.0 cm quartz cells. The X-ray powder diffraction was measured using a Philips X-ray PW 1710 with Cu Ka radiation (l ¼ 1.5405 °A) with 40 kV and 30 mA. The scanning rate was maintained at 0.06 scans per minute, in the 2q range of 4–80.

2.3. Standard and Reagent Solutions

A standard solution of FAV (5 × 10−6 M) was prepared in double distilled water. Phloroglucinol (m-trihydroxy benzene; m-THB) solution (32 × 10−3 M) and Tb (III) solution (500 × 10−3 M) were formed in double distilled water. Further dilutions were done using the same solvent to investigate the optimum concentration for the polymerization of m-THB and the optimum concentration for the electro-deposition of Tb.

2.4. Fabrication of TbNPS@ Poly m-THB/PGE

To fabricate the presented electrode, the PGE surface was first washed with double distilled water before use. Further, an electro-polymerization of m-THB was established using 8 × 10−3 M of m-THB solution in phosphate buffer (0.1 M, pH 7) through multiple cyclic voltammetry for 10 cycles using a potential range of −0.9–+1.75 V and scanning rate of 0.1 Vs−1. The electrode was denoted as poly m-THB/PGE. Furthermore, the electrode was submerged in an electrochemical cell having Tb (III) chloride solution (125 × 10−3 M), which was electro-deposited using a potential at −1.2 V for 80 s. The fabricated TbNPs@ poly m-THB/PGE electrode was further characterized and checked by UV-Visible spectrophotometry, CV, SEM and EIS.

2.5. Analytical Procedures for Estimation of FAV

2.5.1. General Analytical Procedure

An appropriate volume of FAV (5 × 10−6 M) standard or sample solution was added into an electrochemical cell filled with 0.1 M phosphate buffer (pH 7) as a supporting electrolyte. The electrochemical performance of FAV using bare and modified PGE was studied using CV and SWV techniques. The experimental variables of the developed method in terms of m-THB polymerization, TbNPs electro-deposition and the optimum electrolyte pH were studied. Moreover, various SWV parameters were studied, including deposition time, frequency, initial potential and step and pulse height.

2.5.2. Procedure for Estimation of FAV in Tablets

Ten Avipiravir® tablets (200 mg per tablet) were weighed, crushed finally and thoroughly mixed. Then, an adequate weight equivalent to 10.0 mg FAV was transferred into a volumetric flask and dissolved into 50 mL of double distilled water. The solution was sonicated for about 20 min, followed by filtration, then the volume was made up to 100 mL with double distilled water to get a concentration of 100 µg mL−1. The developed SWV method was then carried out as mentioned above.

2.5.3. Estimation of FAV in Human Plasma

In a centrifuge tube, 1.0 mL of human plasma was spiked with an adequate amount of FAV solution, and the volume was then furtherly made up to 10 mL using methanol. The mixture was vortexed for 30 seconds and then centrifuged for 35 min (3500 rpm). The resultant supernatant was collected, and appropriate volumes were added to the electrochemical cell. The voltammograms of SWV were recorded for FAV using the modified TbNPs@ poly m-THB/PGE electrode under the optimum experimental conditions. A blank measurement was established in the same way but without the drug. In addition, required dilutions from this supernatant were made using the selected supporting electrolyte. The study was performed following the relevant faculty laws and guidelines, as well as the research ethics committee.

2.6. Characterization of TbNPs@ Poly m-THB/PGE

The developed electrode was morphologically characterized using SEM and the modified polymer layers. Besides this, the XRD and UV–VIS spectra of the modified polymer layers and TbNPS were studied. In addition, the ESI method for bare and TbNPs@ poly m-THB/PGE was examined.

2.7. Validation Data

The proposed SWV method was validated following the ICH guidelines [38] for linearity range, the limit of detection (LOD), the limit of quantification (LOQ), accuracy and precision. The LOD and LOQ values were determined using formulas 3 σ/S and 10 σ/S, respectively, where σ represents the standard deviation of the intercept and S is the slope of the related regression equation. The electrochemical technique’s precision was examined using three different concentrations within the calibration range within the same day (intra-day precision) and across three successive days (inter-day precision). The mean values of relative standard deviations (RSD%) of the results were calculated.

3. Results

3.1. Preparation of TbNPS@ Poly m-THB/PGE

The present research is the first to investigate the electrochemical performance of phloroglucinol; an m-trihydroxy benzene compound (m-THB); on the peak current value of FAV; an antiviral regimen for COVID-19. Since modification of carbon-based electrodes is a promising step to improve electrode surface area and enhance its electron transfer, the electrochemical polymerization of m-THB was performed, which covers the surface of PGE. All experimental variables influencing the polymerization step were examined, such as m-THB concentration, potential, number of polymerization cycles and the scan rate. The concentration of m-THB has a great effect on the polymerization procedure and on the FAV current value. So, concentrations of m-THB from 0.002 to 0.012 M were studied, where the current value was increased by increasing the concentration till constant values of current were obtained using concentrations from 0.007 to 0.009 M, after that, a decrease in current value was found as the resultant polymer film using higher concentration may block the surface of the formed electrode and hence decrease current intensity (Figure 1A). Hence, 0.008 M was selected as the optimum concentration of m-THB and was subsequently used for further measurements. After that, the potential range necessary for m-THB polymerization was tested using different potential values ranging from −0.2 to −1.6 V. An increase in the current value of FAV was obtained by decreasing the potential value until a fixed current value was found at −0.8 V, and it was selected for further electrochemical measurements as represented in Figure 1B.
Owing to the importance of the number of cycles in the polymerization step, as it significantly affects electrode electro-catalytic activity, various numbers of cycles were performed. From data represented in Figure 1C, it was found that 12 cycles showed the highest values and a further decrease in current value was obtained using the number of cycles higher than 12. The scan rate was further tested from 0.05 to 0.4 V s−1, and the highest peak current value was observed at 0.1 V s−1, as represented in Figure S1A (Supplementary Materials).
The formed polymer layers, poly m-THB over the PGE surface, were used as a platform for further loading of Tb NPS, where an electro-deposition of Tb (III) solution was performed. Different concentrations of Tb (III) ranging from 95 to 150 mM were examined; it was observed that the highest and most stable results were obtained using 125 mM, as shown in Figure 1D. Further, deposition potential values required from −1.8 to −0.4 V and various deposition time from 10 to 120 s was examined. It was noticed that −1.2 V and 80 s showed the highest values, and they were used as the optimum parameters, as shown in Figure S1B (Supplementary Materials).

3.2. Electrochemical Performance of FAV at Bare and Modified PGE

The electro-oxidation of FAV was established at bare and modified PGE by both CV and SWV techniques. Figure 2A shows the distinct oxidation peak of FAV (70 × 10 −9 M) at potential 1.14 V using bare PGE (curve a), poly m-THB/PGE (curve b) in 0.1 M phosphate buffer, pH 7.0. The oxidation current values of FAV were 45 and 75 μA, respectively. Furthermore, Figure 2A (curve c) represented the deposition of Tb nanocomposites over poly m-THB/PGE surface, which remarkably enhanced the sensitivity towards FAV electro-oxidation, giving a higher current value (~127 μA) in comparison with bare PGE or poly m-THB/PGE which may be attributed to their good electro-activity, large surface areas and rapid transfer rate on the modified electrode surface. These findings clearly confirm the synergistic effect of the used hybrid composites, m-THB polymer and Tb NPS, in electrode composition.

3.3. Characterization of TbNPs@ Poly m-THB/PGE

The morphological characterization of the fabricated electrodes was carried out by SEM technique, where SEM images of poly m-THB and TbNPs@ poly m-THB were represented in Figure 2. The SEM images of the bare PGE electrode are represented in Figure 2C, where distinguishable smooth layers [32] covering its surface can be observed. However, after polymerization with m-THB, obvious lumps and flake-like structures were observed coating the surface of the modified electrode, as shown in Figure 2D. After incorporation of TbNPS over the surface of poly m-THB/PGE electrode, characteristic lumps and depressions structures with glowing clusters were observed over the surface of the modified electrode TbNPS @ poly m-THB/PGE electrode as shown in Figure 2E.
The used modification forms porous structures covering the electrode surface, which improves the active surface area of the electrode and enhances FAV oxidation. Moreover, the XRD pattern showed diffraction peaks centered around values of 28.76_and 47.50, which are in agreement with the diagnostic peaks of Tb, as shown in Figure S2A.
Figure S2B (Supplementary Materials) represents the UV spectra of m-THB, Tb and TbNPs@ poly m-THB hybrid composite. As shown by curve i, a distinguished maximum peak of m-THB was observed at 268 nm. In addition, a characteristic peak of Tb was found at ~220 nm, as represented in curve ii. In curve iii (spectrum of TbNPs@ poly m-THB hybrid modifier), another peak appeared at ~330 nm, which confirms the success of polymerization of m-THB, besides the characteristic peak of Tb at ~220 nm.

3.4. Investigation of Scan Rate

The investigation of the scan rate on the oxidation peak current of FAV in phosphate buffer (0.1 M, pH 7.0) using the fabricated electrode was performed by examining the related CV voltammograms at various scan rates from 100 to 900 mV/s. The peak current values of FAV were directly proportional to the scan rate, as shown in Figure 3, conforming Randles-Ševćik equation [39]. Figure 3A represents the enhancement in the anodic peak current by increasing the scan rate from 100 to 900 mV/s. The relationship between the oxidation peak current (Ip) and the scan rate (ʋ) showed a linear response following the equation below:
Ip (µA) = 15.8 + 121.7 ʋ   (r2 = 0.9924)
From Figure 3A, by increasing the scan rate, the oxidation potential of FAV was moved to more positive values, with an increase in the current intensity ensuring the irreversibility of the oxidation process of FAV. From data represented in Figure 3B, a plot of the logarithm of the oxidation peak current (log Ip) versus the logarithm of the scan rate (log ʋ) was found to be linear and was described by the following regression equation:
log Ip (µA) = 2.11 + 0.72 log ʋ(V s−1)  (r2 = 0.996)
The slope of the linear equation between log Ip versus log ʋ was 0.72. Hence the oxidation process of FAV is controlled by both adsorption and diffusion mechanisms, which agrees with the previous studies [18,19,20,21].
Further, by plotting potential (Ep) against the logarithm of scan rate (log ʋ), a linear relationship was obtained as represented in Figure 3B and described with the following regression equation:
Ep (V) = 0.947 + 0.052 log ʋ (V s−1)  (r2 = 0.987)
As represented in Figure 2B, no cathodic peak for FAV was observed in the CV reverse scan, confirming the irreversibility of the oxidation reaction of FAV. Based on the Laviron equation [40], the potential (E), number of transferred electrons (n) and scan rate in the rate-limiting step can be calculated from:
The slope of the plot Ep (V) and log ʋ = 2.2303 RT/αn F
T is the absolute temperature (298 K), n is the number of transferred electrons in the rate-determining step, R is the universal gas constant (8.314 J mol−1 K−1) and F is the Faraday constant (96.480 C mol−1). Assuming α (the transfer coefficient) is 0.5 in totally irreversible reactions, and after substitution of the slope with 0.052, the number of electrons involved in the oxidation process was calculated to be ≈2.0; this agrees with previously reported articles [20,21]. The oxidation reaction of FAV probably occurs in the aromatic hydroxyl group on the pyrazine ring in the FAV chemical structure, as mentioned before [19,20].

3.5. Electrochemical Characterization of TbNPs@ Poly m-THB/PGE

The electrochemical activity of TbNPs@ poly m-THB/PGE was examined using the CV technique, where Fe2+/Fe3+ solution (1.0 mmol L−1) prepared in 0.5 M of potassium chloride was used. After using the modified sensor, an increment in peak current intensity in the reduction-oxidation peak of the Fe2+/Fe3+ system was observed, as represented in Figure 4A. This increment is due to an increase in the active surface area of the electrode after modification. This finding was affirmed by the EIS study, where measurements were performed at 10 mV, and the potential amplitude was within the frequency range (1.0–10 KHz). TbNPs@ poly m-THB/PGE electrode showed lower series resistance than that of the bare one. Moreover, the results in Figure 4B shows that bare PGE has displayed a semi-circular model, but TbNPs@ poly m-THB/PGE modified electrode displayed a straight linear curve. This indicates the improvement in the electrical conductivity due to the charge transfer acceleration and the surface area enlargement. In order to confirm this hypothesis, the electrode’s active surface area was calculated using the Randles–Ševćik equation from the slope of anodic peak current (Ip):
Ipa = (2.69 × 105) n3/2AeffDR1/2C0υ1/2
Aeff is the electrode surface area in cm2, n is the number of electron transfers, DR is the diffusion coefficient (cm2 s−1), C0 is the concentration of Fe2+/Fe3+ system (mol/cm2) and υ is the scan rate (V s−1). According to the Randles–Ševćik equation, the active surface areas of bare PGE and TbNPs@ poly m-THB/PGE have been calculated to be: 0.212 and 0.454 cm2. This finding confirmed the improvement action of using the hybrid modification (m-THB polymer layers and TbNPS) regarding the oxidation of FAV using a TbNPs@ poly m-THB/PGE electrode.

3.6. Optimization of Method’s Parameters

3.6.1. Effect of pH

Supporting electrolyte pH is very important to study the electrochemical behavior of FAV at the modified electrode. Therefore, different phosphate buffer solutions (0.1 M) from pH 4.0 to 9.0 were examined. An increase in the current value is observed by increasing the pH value. A phosphate buffer of pH 7.0 showed the highest value, and it was selected for further measurements, as represented in Figure S3A (Supplementary Materials). FAV molecule has two tautomeric forms, a more stable enol form and a ketone form, and the intersection point of the Ep/pH curves with a clear change in the peak intensity at about 7.0–8.0 may be explained by the replacement of one mechanism (reaction with enol) by another (reaction with ketone) in the tautomeric equilibrium of FAV. A linear plot between the pH values and their corresponding potential was represented in Figure S3B (Supplementary Materials), where the potential of the FAV oxidation peak was moved to less positive potential values upon increasing the pH value. It is noteworthy that Ep (V) = 1.122 + 0.053 pH (r = 0.994), which reveals the proton-dependent nature of FAV on the modified electrode. The value of the slope is close to the theoretical value of 59 mV; hence the number of electrons and protons involved in the electrochemical oxidation of FAV are equal. These findings are in agreement with the number of electrons (≈ 2.0 electrons) included in the oxidation of FAV, which is calculated above using the Laviron equation, and also in agreement with previously reported methods [19,20,21,22].

3.6.2. SWV Parameters

Instrumental parameters affecting the proposed SWV, such as pulse height, step height and frequency, were studied in the ranges 3–30 mV, 1–30 mV and 25–250 V s−1, respectively. It was observed that pulse height at 5 mV, step height at 3 mV and frequency at 100 V s−1 were the optimal variables for electro-oxidation of FAV at the modified electrode. Besides, the initial potential and deposition time parameters of FAV were examined from −1.2 to + 0.8 V and from 10 to 90 s, and optimum values were −0.2 V and 60 s, respectively.

3.7. Validation Study

3.7.1. Linearity and Sensitivity Limits

The calibration curve of FAV over a concentration range from 10–150 × 10−9 M was constructed under the optimum conditions as represented in Figure S4 (Supplementary Materials). The values of LOD and LOQ were 3.1 and 9.3 × 10 −9 M, respectively. Various statistical parameters of the proposed SWV method are represented in Table 1. The proposed method showed higher sensitivity than various previously reported methods.

3.7.2. Accuracy and Precision

The accuracy, repeatability and intermediate inter-day precisions for the proposed method were investigated. Table 2 summarizes the obtained results. The intra-day precision was evaluated by repeating the measurements of three various concentration levels of FAV working solutions (20, 70 and 120 × 10−9 M). The measurements were repeated over three consecutive days to examine the inter-day precision. Recovery results were observed to be from 98.92 to 101.42%, indicating acceptable accuracy. In addition, the % RSD values were calculated, and the results were less than 1.8%.

3.7.3. Selectivity

The effect of commonly co-existing interfering substances during FAV analysis was examined in order to evaluate the selectivity of the fabricated TbNPS@ poly m-THB/PGE electrode. The concentration of each substance was tested at 10 folds the concentration of the drug used during the electrochemical measurement. The percentage recovery values were in the range of 96.8–100.2% in the presence of various substances ensuring high selectivity of the proposed SWV method for FAV estimation (Table 3).

3.8. Method Applications

3.8.1. Estimation of FAV in Pharmaceutical Tablet

The fabricated TbNPS@ poly m-THB/PGE electrode showed high sensitivity (LOD = 3.1 × 10 −9 M); hence it was successfully used to determine FAV in commercial tablets. Acceptable recovery results were obtained, ranging from 99.58–100.93% ± 1.2–1.9, ensuring the absence of interference from commonly used excipients, as represented in Table 4. The obtained percentage recovery results were statistically compared to those calculated according to a previously published method [7]. The % recovery of the proposed method was 98.9 ± 1.2 when compared with that of the reported one (97.5 ± 1.6). Moreover, the calculated values of the t- and F-tests (n = 5) were 0.63 and 2.35, respectively, ensuring a lack of significant difference between the proposed and the published methods.

3.8.2. Estimation of FAV in Human Plasma

The fabricated electrode TbNPS@ poly m-THB/PGE was employed for FAV quantitation in human plasma, where a calibration curve of human plasma samples spiked with FAV was constructed in concentrations ranging from 15 to 90 × 10−9 M to assess linearity. A good linearity was obtained with a correlation coefficient equal to 0.9994. The regression equation is Y = 0.81 + 2.04 X (n = 3); Y is the current value, and X is FAV concentration.
Moreover, % recovery was calculated, and the results ranged from 97.39 to 101.93% with RSD% values less than 2.5, as represented in Table 4. The acceptable results confirm the efficiency of the established SWV method utilizing TbNPS@ poly m-THB/PGE for the detection of FAV without interferences from plasma constituents. The results obtained confirm the method’s sensitivity and applicability for the determination of FAV in human plasma samples.

3.9. Stability and Reproducibility of the Fabricated Sensor

The stability of the modified TbNPS@ poly m-THB/PGE electro-sensor was examined, where the sensor was stored at 4 °C for 20 successive days, and the electrochemical behavior of FAV was assessed every 2 days. The storage stability of TbNPS@ poly m-THB/PGE was illustrated by the measured current (Figure S5A, Supplementary Materials) with a 98.53% retention of the original, optimized current values. Moreover, FAV (70 × 10−9 M) was analyzed using six parallel-prepared modified electrodes fabricated using the same procedure. The corresponding RSD% value didn’t exceed 2.1% during the analysis, which proves the good reproducibility of the modified sensor, as shown in Figure S5B, Supplementary Materials.
The presented SWV method showed simplicity, good selectivity and high sensitivity utilizing the novel electrode (TbNPS@ poly m-THB/PGE) in comparison with previously published articles, as represented in Table 5. Some of the reported methods suffered from several demerits like insufficient sensitivity, complicated procedures or the need for large amounts of organic solvents. This confirms the excellent applicability of the proposed SWV for drug analysis in different media.

4. Conclusions

An innovative and highly sensitive electrochemical sensor was fabricated based on utilizing Tb nanoparticles supported over new polymer layers of m-THB. The performance of the fabricated sensor was examined for studying the electro-oxidation of FAV using the SWV technique. CV, SEM, XRD, UV-spectrophotometry and EIS techniques were conducted for further characterization. TbNPs and poly m-THB had synergistic effects, which enhanced the determination of FAV in tablets and in human plasma. A full validation study of the proposed method was carried out according to the ICH guidelines. The proposed sensor showed good recovery results for the demonstration of FAV in different matrices without any interference. Besides, it has high sensitivity and simplicity in fabrication, and this ensured good performance of fabricated senor in FAV determination in complex matrices. Notably, this study is the first to be reported for the investigation of the electrochemical performance of the modified electrode (TbNPS @poly m-THB/PGE) in the analysis of FAV.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/bios13020243/s1, Figure S1: Effect of (A) scan rate on the current of FAV (70 × 10−9 M) in electro-polymerization process of m-THB, and (B) deposition potential of Tb (III) solution; Figure S2: (A) XRD spectrum of Tb nanoparticles and (B) Uv spectra of: (i) m-THB, (ii) Tb and (iii) poly m-THB& Tb hybrid composite; Figure S3: (A) The effect of pH of supporting electrolyte pH on the oxidation peak of FAV (70 × 10−9 M), and (B) Linear plot between potential and pH values of the supporting electrolytes; Figure S4: Square wave voltammograms for various concentrations of FAV (10–150 × 10−9 M) monitored on TbNPS@ poly m-THB/PGE electrode.; Figure S5: Bar diagram curves obtained for (A) stability studies of TbNPS@ poly m-THB/PGE modified electrode over 20 days and (B) recording six different times to attain reproducibility study of TbNPS@ poly m-THB/PGE in the presence of FAV (70 × 10−9 M).

Author Contributions

Conceptualization, M.F.B.A. and A.E.I.; methodology, M.F.B.A. and B.I.S.; software, M.F.B.A. and A.E.I.; validation, M.F.B.A., R.E.S. and B.I.S.; formal analysis, R.E.S. and B.I.S.; investigation, R.E.S. and A.E.I.; resources, R.E.S., B.I.S. and A.E.I.; data curation, R.E.S. and A.E.I.; writing—original draft preparation, R.E.S., B.I.S. and M.F.B.A.; writing—review and editing, B.I.S., M.F.B.A. and A.E.I.; visualization, M.F.B.A. and S.E.D.; supervision, M.F.B.A. and S.E.D.; project administration, M.F.B.A. and S.E.D.; funding acquisition, S.E.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Joshi, S.; Parkar, J.; Ansari, A.; Vora, A.; Talwar, D.; Tiwaskar, M.; Patil, S.; Barkate, H. Role of favipiravir in the treatment of COVID-19. Int. J. Infect. Dis. 2021, 102, 501–508. [Google Scholar] [CrossRef]
  2. Cai, Q.; Yang, M.; Liu, D.; Chen, J.; Shu, D.; Xia, J.; Liao, X.; Gu, Y.; Cai, Q.; Yang, Y. Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering 2020, 6, 1192–1198. [Google Scholar] [CrossRef]
  3. Ioannidis, J.P.A. The end of the COVID-19 pandemic. Eur. J. Clin. Investig. 2022, 52, e13782. [Google Scholar] [CrossRef]
  4. Murray, C.J. COVID-19 will continue but the end of the pandemic is near. Lancet 2022, 399, 417–419. [Google Scholar] [CrossRef]
  5. Sharaf, Y.A.; El Deeb, S.; Ibrahim, A.E.; Al-Harrasi, A.; Sayed, R.A. Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen. Molecules 2022, 27, 2330. [Google Scholar] [CrossRef]
  6. Megahed, S.M.; Habib, A.A.; Hammad, S.F.; Kamal, A.H. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2020, 249, 119241. [Google Scholar] [CrossRef]
  7. Mikhail, I.E.; Elmansi, H.; Belal, F.; Ehab Ibrahim, A. Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens. Microchem. J. 2021, 165, 106189. [Google Scholar] [CrossRef]
  8. El Sharkasy, M.E.; Tolba, M.M.; Belal, F.; Walash, M.; Aboshabana, R. Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: Application to pharmaceutical formulations and biological fluids. Luminescence 2022, 37, 953–964. [Google Scholar] [CrossRef]
  9. Ibrahim, A.E.; Sharaf, Y.A.; El Deeb, S.; Sayed, R.A. Analytical Performance and Greenness Evaluation of Five Multi-Level Design Models Utilized for Impurity Profiling of Favipiravir, a Promising COVID-19 Antiviral Drug. Molecules 2022, 27, 3658. [Google Scholar] [CrossRef]
  10. Noureldeen, D.A.M.; Boushra, J.M.; Lashien, A.S.; Hakiem, A.F.A.; Attia, T.Z. Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs “Remdesivir and Favipiravir”: Green assessment with application to pharmaceutical formulations and human plasma. Microchem. J. 2022, 174, 107101. [Google Scholar] [CrossRef]
  11. Saraya, R.E.; Deeb, S.E.; Salman, B.I.; Ibrahim, A.E. Highly sensitive high-performance thin-layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulations. J. Sep. Sci. 2022, 45, 2582–2590. [Google Scholar] [CrossRef]
  12. Bulduk, İ. HPLC-UV method for quantification of favipiravir in pharmaceutical formulations. Acta Chromatogr. 2021, 33, 209–215. [Google Scholar] [CrossRef]
  13. Marzouk, H.M.; Rezk, M.R.; Gouda, A.S.; Abdel-Megied, A.M. A Novel Stability-Indicating HPLC-DAD Method for Determination of Favipiravir, a Potential Antiviral Drug for COVID-19 Treatment; Application to Degradation Kinetic Studies and In-Vitro Dissolution Profiling. Microchem. J. 2022, 172, 106917. [Google Scholar] [CrossRef]
  14. Rezk, M.R.; Badr, K.A.; Abdel-Naby, N.S.; Ayyad, M.M. A novel, rapid and simple UPLC–MS/MS method for quantification of favipiravir in human plasma: Application to a bioequivalence study. Biomed. Chromatogr. 2021, 35, e5098. [Google Scholar] [CrossRef]
  15. Morsy, M.I.; Nouman, E.G.; Abdallah, Y.M.; Zainelabdeen, M.A.; Darwish, M.M.; Hassan, A.Y.; Gouda, A.S.; Rezk, M.R.; Abdel-Megied, A.M.; Marzouk, H.M. A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers. J. Pharm. Biomed. Anal. 2021, 199, 114057. [Google Scholar] [CrossRef]
  16. Emam, A.A.; Abdelaleem, E.A.; Abdelmomen, E.H.; Abdelmoety, R.H.; Abdelfatah, R.M. Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient’s plasma. Microchem. J. 2022, 179, 107580. [Google Scholar] [CrossRef]
  17. Onmaz, D.E.; Abusoglu, S.; Onmaz, M.; Yerlikaya, F.H.; Unlu, A. Development and validation of a sensitive, fast and simple LC-MS/MS method for the quantitation of favipiravir in human serum. J. Chromatogr. B 2021, 1176, 122768. [Google Scholar] [CrossRef]
  18. Allahverdiyeva, S.; Yunusoğlu, O.; Yardım, Y.; Şentürk, Z. First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode. Anal. Chim. Acta 2021, 1159, 338418. [Google Scholar] [CrossRef]
  19. Kanbeş Dindar, Ç.; Bozal-Palabiyik, B.; Uslu, B. Development of a Diamond Nanoparticles-based Nanosensor for Detection and Determination of Antiviral Drug Favipiravir. Electroanalysis 2022, 34, 1174–1186. [Google Scholar] [CrossRef]
  20. Mehmandoust, M.; Khoshnavaz, Y.; Tuzen, M.; Erk, N. Voltammetric sensor based on bimetallic nanocomposite for determination of favipiravir as an antiviral drug. Microchim. Acta 2021, 188, 434. [Google Scholar] [CrossRef]
  21. Akca, Z.; ÖZOK, H.İ.; Yardim, Y.; Şentürk, Z. Electroanalytical investigation and voltammetric quantification of antiviral drug favipiravir in the pharmaceutical formulation and urine sample using a glassy carbon electrode in anionic surfactant media. Turk. J. Chem. 2022, 46, 869–880. [Google Scholar] [CrossRef]
  22. Mohamed, M.A.; Eldin, G.M.; Ismail, S.M.; Zine, N.; Elaissari, A.; Jaffrezic-Renault, N.; Errachid, A. Innovative electrochemical sensor for the precise determination of the new antiviral COVID-19 treatment Favipiravir in the presence of coadministered drugs. J. Electroanal. Chem. 2021, 895, 115422. [Google Scholar] [CrossRef]
  23. El-Wekil, M.M.; Hayallah, A.M.; Abdelgawad, M.A.; Abourehab, M.A.; Shahin, R.Y. Nanocomposite of gold nanoparticles@ nickel disulfide-plant derived carbon for molecularly imprinted electrochemical determination of favipiravir. J. Electroanal. Chem. 2022, 922, 116745. [Google Scholar] [CrossRef]
  24. Erçarıkcı, E.; Aksu, Z.; Topçu, E.; Kıranşan, K.D. ZnS Nanoparticles-decorated Composite Graphene Paper: A Novel Flexible Electrochemical Sensor for Detection of Dopamine. Electroanalysis 2022, 34, 91–102. [Google Scholar] [CrossRef]
  25. Erçarıkcı, E.; Aksu, Z.; Dağcı Kıranşan, K.; Topçu, E. Graphene paper with electrodeposited NiCo2S4 nanoparticles as a novel flexible sensor for simultaneous detection of folic acid and ascorbic acid. Diam. Relat. Mater. 2022, 121, 108713. [Google Scholar] [CrossRef]
  26. Abdel-aal, F.A.; Ali, M.F. Eco-friendly fabricated electrochemical sensor using red cabbage extract for electrochemical determination of dacarbazine with the aid of factorial design approach. J. Electrochem. Soc. 2017, 164, H1053. [Google Scholar] [CrossRef]
  27. Ali, M.F.; El-Zahry, M.R. A comparative study of different electrodeposited NiCo 2 O 4 microspheres anchored on a reduced graphene oxide platform: Electrochemical sensor for anti-depressant drug venlafaxine. RSC Adv. 2019, 9, 31609–31620. [Google Scholar] [CrossRef]
  28. El-Zahry, M.R.; Ali, M.F. A novel polymer integrated Vertically-Oriented reduced graphene oxide sheets supported over palladium nanoparticles based sensor for Real-Time monitoring of Sorafenib; a Multi-kinase inhibitor in complex biological samples. Microchem. J. 2022, 180, 107549. [Google Scholar] [CrossRef]
  29. Zhao, X.; Chen, X.; Yu, X.; Ding, X.; Yu, X.; Tang, K. High sensitivity humidity sensor and its application in nondestructive testing for wet paper. Sens. Actuators B Chem. 2019, 301, 127048. [Google Scholar] [CrossRef]
  30. Vishnu, N.; Gandhi, M.; Badhulika, S.; Kumar, A.S. Tea quality testing using 6B pencil lead as an electrochemical sensor. Anal. Methods 2018, 10, 2327–2336. [Google Scholar] [CrossRef]
  31. Ramanaviciene, A.; Plikusiene, I. Polymers in Sensor and Biosensor Design. Polymers 2021, 13, 917. [Google Scholar] [CrossRef]
  32. Hosny, N.M.; Ali, M.F. Emphasis on the incorporation of Tropaeolin OO dye and silver nanoparticles for voltammetric estimation of flibanserin in bulk form, tablets and human plasma. Talanta 2022, 245, 123420. [Google Scholar] [CrossRef]
  33. Ali, M.F.; Abdel-Aal, F.A. In situ polymerization and FT-IR characterization of poly-glycine on pencil graphite electrode for sensitive determination of anti-emetic drug, granisetron in injections and human plasma. RSC Adv. 2019, 9, 4325–4335. [Google Scholar] [CrossRef]
  34. Mahanthesha, K.; Swamy, B.K.; Chandra, U. Simultaneous determination of dopamine at poly (Pyrogallol) modified carbon paste electrode: A Voltammetric Study. IJRAR-Int. J. Res. Anal. Rev. (IJRAR) 2018, 5, 1252–1257. [Google Scholar]
  35. Sukanya, R.; Sakthivel, M.; Chen, S.-M.; Chen, T.-W. A new type of terbium diselenide nano octagon integrated oxidized carbon nanofiber: An efficient electrode material for electrochemical detection of morin in the food sample. Sens. Actuators B: Chem. 2018, 269, 354–367. [Google Scholar] [CrossRef]
  36. Baytak, A.K.; Duzmen, S.; Teker, T.; Aslanoglu, M. A novel modified electrode based on terbium oxide and carbon nanotubes for the simultaneous determination of methyldopa and paracetamol. Anal. Methods 2016, 8, 4711–4719. [Google Scholar] [CrossRef]
  37. Gadallah, M.I.; Ali, H.R.H.; Askal, H.F.; Saleh, G.A. Development of terbium based sensor for determination of imipenem in dosage forms and real samples. J. Mol. Liq. 2019, 276, 705–713. [Google Scholar] [CrossRef]
  38. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2 (R1) Geneva. 2005. Available online: http://www.ich.org (accessed on 6 June 2021).
  39. Bard, A.J.; Faulkner, L.R.; White, H.S. Electrochemical Methods: Fundamentals and Applications; John Wiley & Sons: Hoboken, NJ, USA, 2022. [Google Scholar]
  40. Laviron, E. General expression of the linear potential sweep voltammogram in the case of diffusionless electrochemical systems. J. Electroanal. Chem. Interfacial Electrochem. 1979, 101, 19–28. [Google Scholar] [CrossRef]
Figure 1. The effects of: (A) concentration of m-THB, (B) potential used in the polymerization of m-THB, (C) number of cycles for polymerization of m-THB and (D) concentration of Tb (III) on the current value of FAV (70 × 10−9 M) using TbNPS @ poly m-THB/PGE.
Figure 1. The effects of: (A) concentration of m-THB, (B) potential used in the polymerization of m-THB, (C) number of cycles for polymerization of m-THB and (D) concentration of Tb (III) on the current value of FAV (70 × 10−9 M) using TbNPS @ poly m-THB/PGE.
Biosensors 13 00243 g001
Figure 2. (A) SWVs, (B) CVs curves of FAV (70 × 10−9 M) recorded on: (a) bare PGE, (b) poly m-THB/PGE and (c) TbNPS@ poly m-THB/PGE & SEM images of: (C) bare PEG, (D) poly m-THB/PGE, and (E) Tb NPS@ poly m-THB/PGE surface.
Figure 2. (A) SWVs, (B) CVs curves of FAV (70 × 10−9 M) recorded on: (a) bare PGE, (b) poly m-THB/PGE and (c) TbNPS@ poly m-THB/PGE & SEM images of: (C) bare PEG, (D) poly m-THB/PGE, and (E) Tb NPS@ poly m-THB/PGE surface.
Biosensors 13 00243 g002
Figure 3. (A) The effect of different scan rates from 0.1 to 0.9 V s−1 on CVs curves of FAV (70 × 10−9 mol L−1), Inset: Scan rate calibration plot and (B) Dependence of logarithm peak current (Ip/µA) and the oxidation peak potential (E/V) on the logarithm of scan rate (log ν/Vs−1).
Figure 3. (A) The effect of different scan rates from 0.1 to 0.9 V s−1 on CVs curves of FAV (70 × 10−9 mol L−1), Inset: Scan rate calibration plot and (B) Dependence of logarithm peak current (Ip/µA) and the oxidation peak potential (E/V) on the logarithm of scan rate (log ν/Vs−1).
Biosensors 13 00243 g003
Figure 4. (A) Cyclic voltammograms and (B) Nyquist plot of 1.0 mM of Fe3+/Fe2+ solution recorded on bare PGE and TbNPS@ poly m-THB/PGE electrodes. Working parameters are: scan rate 50 mV s−1 over a potential range of −0.2–0.6 V.
Figure 4. (A) Cyclic voltammograms and (B) Nyquist plot of 1.0 mM of Fe3+/Fe2+ solution recorded on bare PGE and TbNPS@ poly m-THB/PGE electrodes. Working parameters are: scan rate 50 mV s−1 over a potential range of −0.2–0.6 V.
Biosensors 13 00243 g004
Table 1. Linearity results for FAV determination by the proposed SWV method using TbNPS@ poly m-THB/PGE electrode.
Table 1. Linearity results for FAV determination by the proposed SWV method using TbNPS@ poly m-THB/PGE electrode.
ParameterFAV
Linearity range (×10−9 M)10–150
Correlation coefficient (r) 0.9994
Intercept (a) ± SD *1.46 ± 2.33
Slope (b) ± SD *2.5 ± 0.04
LOD ** (×10−9 M)3.08
LOQ ** (×10−9 M)9.32
* Average of four replicates. ** Detection (LOD) and quantification (LOQ) limits were calculated as 3.3 σ/b and 10 σ/b, respectively, where σ is the standard deviation of the intercept of the regression equation and b is the slope of the calibration curve.
Table 2. Accuracy and precision results for determination of FAV under the developed SWV method.
Table 2. Accuracy and precision results for determination of FAV under the developed SWV method.
Authentic DrugConc.
(×10−9 M)
AccuracyIntra-Day PrecisionInter-Day Precision
FAV20% Recovery *%RSD *% Recovery *%RSD *%Recovery *% RSD *
100.361.2599.530.99100.641.77
7098.920.93101.421.81101.321.34
120101.141.36100.161.4399.751.11
* Average of three replicates; Results are compared with those of the standard calibration curve.
Table 3. Selectivity of the proposed SWV method for determination of FAV.
Table 3. Selectivity of the proposed SWV method for determination of FAV.
Interfering MaterialInter-Day Precision
% Recovery *% RSD *
Uric acid99.31.2
Oxalic acid100.2 0.9
Sucrose97.31.1
Starch99.11.4
Magnesium chloride97.71.3
Citric acid96.81.5
L-Ascorbic acid97.21.7
* Average of three replicates; FAV: Interfering substance (1: 10).
Table 4. Determination of FAV in tablets and human plasma using TbNPS@ poly m-THB/PGE electrode.
Table 4. Determination of FAV in tablets and human plasma using TbNPS@ poly m-THB/PGE electrode.
SampleAdded Amount (nM)Found Concentration (nM)%Recovery a ± %RSD
Avipiravir® Tablet2020.09100.45 ± 1.2
8078.8798.58 ± 1.6
120121.12100.93 ± 1.9
Human plasma3029.5698.53 ± 2.1
5050.07100.14 ± 1.8
7071.35101.93 ± 1.5
120116.8797.39 ± 1.7
Proposed method Reported method [8]t-value bF-Value b
98.9 ± 1.297.5 ± 1.60.632.35
a Average of three replicates. b Theoretical values at 95% confidence limit; t = 2.228, F = 5.053; (n = 6).
Table 5. Comparison between the proposed method for determination of FAV to previously reported methods.
Table 5. Comparison between the proposed method for determination of FAV to previously reported methods.
TechniqueLinearity RangeLODApplicationRef.
HPLC0.5–50 µg/mL0.04 µg/mLTablet[5]
Spectrofluorimetry40–280 ng/mL9.44 ng/mLTablet/human plasma[6]
Synchronous Fluorimetry1–18 ng/mL0.25 ng/mLTablet/human plasma[8]
HPTLC3.75–100 µg/mL1.12 µg/mLPure form/Tablet[11]
HPLC-UV10–100 µg/mL1.2 µg/mLTablet[12]
HPLC-DAD6.25–250 µg/mL1.02 µg/mLTablet[13]
UPLC-MS/MS0.25–16 µg/mL0.075 µg/mLHuman plasma[14]
LC-MS/MS0.048–50 µg/mL0.045 µg/mLHuman serum[17]
LC-MS/MS0.1–20 µg/mL0.03 µg/mLTablet &plasma[15]
UPLC0.1–10 µg/mL0.03 µg/mLHuman plasma[16]
SWV0.01–0.1 µg/mL
0.1–20 µg/mL
3 ng/mLTablet/human urine[18]
SWV1.56–31.2 µg/mL0.76 ng/mLTablet/serum[19]
SWV864–0.157 µg/mL0.017 µg/mLTablet/urine[22]
DPV0.014–0.31 µg/mL0.072 ng/mLTablet/plasma & urine[20]
SWV1–100 µg/mL0.26 μg/mLTablet/urine[21]
SWV1.57–23.6 ng/mL0.486 ng/mLTablets & human plasmaProposed study
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ali, M.F.B.; Saraya, R.E.; El Deeb, S.; Ibrahim, A.E.; Salman, B.I. An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19. Biosensors 2023, 13, 243. https://0-doi-org.brum.beds.ac.uk/10.3390/bios13020243

AMA Style

Ali MFB, Saraya RE, El Deeb S, Ibrahim AE, Salman BI. An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19. Biosensors. 2023; 13(2):243. https://0-doi-org.brum.beds.ac.uk/10.3390/bios13020243

Chicago/Turabian Style

Ali, Marwa F. B., Roshdy E. Saraya, Sami El Deeb, Adel Ehab Ibrahim, and Baher I. Salman. 2023. "An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19" Biosensors 13, no. 2: 243. https://0-doi-org.brum.beds.ac.uk/10.3390/bios13020243

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop